SCP-9832 Thaumiel ~ medium confidence
SCP-9832
Expected annual
$62.7M
One-time setup
$58.5M
Annual recurring
$61.1M
Personnel
86
First-year one-time capital and setup costs are approximately $58.5M with ongoing annual operating costs ~ $61.1M; main drivers are facility construction and hardening, personnel and medical surveillance, raw-material scarcity and per-dose manufacturing, and large contingency/reserve funds. Analyst scale scenarios (notes #29 and #30) indicate first-year program costs could range widely depending on scale and outsourcing choices.
🏗️ One-Time Capital Costs Total: $58.5M
Facilities $20.0M
[#1, #16, #21] Cleanroom/manufacturing facility construction, initial site hardening and quarantine ward build-outs; includes gowning areas, HVAC validation and structural work for containment and isolation.
Opportunity Risk Reserve $20.0M
[#24] Program risk capital / insurance reserve for large escalatory recontainment/legal actions (one-time capital set-aside).
Equipment $5.2M
[#2, #20] Manufacturing and laboratory equipment (bioreactors, HPLC/GC/MS, sterile fillers, lyophilizers, autoclaves) plus cryostorage hardware.
Personnel Training Initial $5.0M
[#10] Initial cognitive-safety training and certification for large initial cohort (simulator training, baseline testing).
Mass Dosing Campaign $3.5M
[#11] Initial mass administration campaign logistics: staffing, scheduling, on-site observation, record-keeping for first rollout.
Personnel Vetting One Time $1.5M
[#8] Initial background investigations and high-level clearance processing for initial vetted staff.
Secure Info Storage $1.0M
[#7] Air-gapped servers, hardware security modules, encrypted backups and tamper-evident audit log systems setup.
Cold Chain And Storage Infrastructure $500K
[#6] Ultra-low freezers, temperature-controlled containers, monitoring systems and initial backup power provisioning.
Inventory System One Time $500K
[#18] Secure dose-tracking software and tamper-evident chain-of-custody system customization.
Pharmacovigilance It One Time $500K
[#27] Initial secure IT systems build for adverse-event logging and cognitive-effect databases.
Legal And Cover Setup $500K
[#17] Initial setup for cover-story infrastructure, shell entities, and legal/PR groundwork.
Communications Security One Time $200K
[#25] Development of cognitohazard-neutral messaging protocols and initial materials to safely communicate about the serum.
Ppe One Time $100K
[#22] Initial purchase of specialized PPE, powered respirators and decontamination gear for production handlers.
Initial Research And Lab Setup $0
[]
🔄 Annual Recurring Costs Total: $61.1M/yr
Long Term Medical Surveillance $10.0M/yr
[#12] Annual neurocognitive testing, imaging, pharmacovigilance and follow-up care for inoculated population.
Adverse Event Reserve $10.0M/yr
[#13] Annual reserve/contingency set aside to handle adverse events, acute care and emergency R&D responses (5–20% style reserve).
Replacement And Recall Losses $10.0M/yr
[#26] Annual losses from expired/recall waste and replacement manufacturing (shelf-life and wastage rates).
Staff Wages $8.0M/yr
[#9, #23] Annual payroll for medical staff, scientists, QC/production techs, program administrators and support personnel.
Raw Materials $8.0M/yr
[#3] Recurring cost of biological starting materials and GMP reagents per production program assumptions.
Ongoing R&D $5.0M/yr
[#14] Continued mechanism-of-action research, formulation optimization and controlled trials.
Security And Hardening $2.5M/yr
[#16] Recurring armed security, biometric access control maintenance and intrusion-detection operations across production and storage sites.
Cover Story And Legal $2.0M/yr
[#17] Ongoing legal, PR and cover-story operations, FOIA handling and related activities.
Personnel Training Refreshers $1.0M/yr
[#10] Annual refresher training and recertification for staff handling cognitohazard-safe procedures.
Quarantine Operations $1.0M/yr
[#21] Staffing and operational costs to run isolation/quarantine wards for affected cohorts.
Facilities Maintenance $500K/yr
[#6, #16] Routine facility maintenance including HVAC validation, sterile environment upkeep, generator/test cycles and utilities.
Logistics And Transport $500K/yr
[#15, #7] Secure transport operations for routine shipments and costs associated with secure couriering of sensitive backups.
Personnel Vetting Recurring $500K/yr
[#8] Renewal background checks, continuous monitoring and psych evaluations for vetted staff.
External Consulting $500K/yr
[#28] Fees for external specialists, ethics oversight and advisory consultations.
Pharmacovigilance It Ops $300K/yr
[#27] Operations and hosting for secure adverse-event databases and analytics.
Supplies And Consumables $200K/yr
[#3, #4, #22] General disposable consumables not otherwise broken out (supplement to raw materials and per-dose items).
Per Dose Consumables $200K/yr
[#4] Vials, stoppers, tamper-evident seals, syringes and cold-chain packaging per annual throughput.
Batch Qc $200K/yr
[#5] Per-batch sterility, potency, endotoxin and analytical testing across expected batch frequency.
Secure Info Maintenance $200K/yr
[#7] Ongoing maintenance, rotation and couriering costs for secure backup infrastructure and HSM maintenance.
Inventory Ops $150K/yr
[#18] Operations and license/support fees for dose tracking, lot control and secure destruction workflows.
Cold Chain Maintenance $100K/yr
[#6] Energy, monitoring, and maintenance for refrigeration and ultra-low freezers.
Communications Security Recurring $100K/yr
[#25] Annual refreshers and updates to cognitohazard-safe messaging protocols.
Waste Handling $50K/yr
[#19] Biohazardous waste disposal, solvent disposal and decontamination services.
Cryostorage Maintenance $50K/yr
[#20] Monitoring and maintenance for cryogenic sample stores holding original anomalous material.
Ppe Replacement $50K/yr
[#22] Ongoing replacement and consumable costs for specialized PPE and decon supplies.
Research And Monitoring $0/yr
[]
Cost Scenarios
📊 Baseline (baseline) $61.1M/yr
91.0% probability / year
Normal operational year with no major incidents; routine manufacturing, surveillance, and contingency funding.
routine production regular surveillance no breaches
🚨 Minor Incident $63.1M/yr
6.0% probability / year +$2.0M vs baseline
Localized containment or adverse-event cluster requiring emergency treatment, limited recall and short-term extra security.
localized contamination small-scale adverse-event cluster limited recall and treatment
🚨 Major Breach $111.1M/yr
3.0% probability / year +$50.0M vs baseline
Significant leak or misuse requiring large-scale recontainment, legal/PR actions, mass medical response and program-wide recall.
mass exposure or civilian leak coordinated malicious use program-wide recontainment operations
👥 Personnel 86 total
Role Count Notes
Research Scientist 10 Senior scientists overseeing formulation and R&D (mapped to #14, #23).
Medical Officer / Nurses 20 Physicians and nurses for administration and acute care (mapped to #9, #12).
QC / Lab Technicians 20 Batch QC, sterility testing and production technicians (mapped to #5, #23).
Security Officer / MTF Agent 15 Armed guards and site security personnel for hardened sites (mapped to #16).
Administrative Staff 10 Program administration, record-keeping and logistics (mapped to #11, #18, #23).
Engineer / Maintenance 5 Facilities, HVAC and equipment maintenance (mapped to #1, #6).
IT / Data Security 5 Secure information storage and pharmacovigilance IT operations (mapped to #7, #27).
Site Director / Executive Staff 1 Program leadership and liaison with governance (mapped to #17, #23).
📋 Confidence Notes
Estimates are order-of-magnitude and built from wide ranges in analyst notes; key uncertainties include per-dose synthesis complexity, reliance on scarce anomalous inputs, desired inoculation scale, and policy choices (outsourcing vs in-house).
← SCP-9831 ↑ All SCPs SCP-9835 →